The relationship between cognitive impairment and cerebral blood flow changes after transient ischaemic attack

Neurological Research

Volumn 35, Issue 6, 2013, Pages 580-585

  Lin, Wang ^a   Jia, Jianping ^a   Wu, Liyong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

High sensitivity C reactive protein; Montreal cognitive assessment; Transcranial doppler; Transient ischaemic attack

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPTH PERCEPTION; DOPPLER FLOWMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; TRANSIENT ISCHEMIC ATTACK; VERBAL BEHAVIOR;

ADULT; AGED; AGED, 80 AND OVER; BLOOD FLOW VELOCITY; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 84879467046     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132813Y.0000000160     Document Type: Article

References (31)

1. Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, et al. Definition and evaluation of transient ischemic attack. Stroke. 2009;40:2276-2293.
2. Johnston SC. Transient ischemic attack. N Engl J Med. 2002;347:1687-1692.
3. Kraaijeveld CL, van Gijn J, Schouten HJ, Staal A. Interobserver agreement for the diagnosis of transient ischemic attacks. Stroke. 1984;15:723-725.
4. Koudstaal PJ, Gerritsma JG, van Gijn J. Clinical disagreement on the diagnosis of transient ischemic attack: is the patient or the doctor to blame? Stroke. 1989;20:300-301.
5. Flossman E, Rothwell PM. Family history of stroke in patients with transient ischemic attack in relation to hypertension and other intermediate phenotypes. Stroke. 2005;36(4):830-835.
6. Johnston SC, Smith WS. Practice variability in management of transient ischemic attacks. Eur Neurol. 1999;42:105-108.
7. Wadley VG, McClure LA, Howard VJ, Unverzagt FW, Go RC, Moy CS, et al. Cognitive status, stroke symptom reports, and modifiable risk factors among individuals with no diagnosis of stroke or transient ischemic attack in the reasons for geographic and racial differences in stroke (REGARDS) study. Stroke. 2007;38:1143-1147.
8. Amarenco P, Bogousslavsky JB, Callahan III A. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-559.
9. Grotta JC, Welch KM, Fagan SC, Lu M, Frankel MR, Brott T, et al. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke. 2001;32:661-668.
10. Bakker FC, Klijn CJM, Jennekens-Schinkel A, van der Tweel I, Tulleken CAF, Kappelle LJ. Cognitive impairment in patients with carotid artery occlusion and ipsilateral transient ischemic attacks. J Neurol. 2003;250(11):1340-1137.
11. MacKenzie G, Gould L, Irelan S, LeBlanc K, Sahlas D. Detecting cognitive impairment in clients with mild stroke or transient ischemic attack attending a stroke prevention clinic. Can J Nuerosci Nurs. 2011;33(1):47-50.
12. Pendlebury ST, Cuthbertson FC, Welch SJV, Mehta Z, Rothwell PM. Underestimation of cognitive impairment by mini-mental state examination versus the montreal cognitive assessment in patients with transient ischemic attack and stroke. Stroke. 2010;41:1290-1293.
13. Dong Y, Sharma VK, Chan BP-L, Venketasubramanian N, Teoh HL, Seet RC, et al. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J Neurol Sci. 2010;299:15-18.
14. Davis SM, Donnan GA. Secondary prevention after ischemic stroke or transient ischemic attack. N Engl J Med. 2012; 366:1914-1922.
15. Wen HB, Zhang ZX, Niu FS, Li L. The application of Montreal cognitive assessment in urban Chinese residents of Beijing. Chin J Intern Med. 2008;47:36-39.
16. Rao R. The role of carotid stenosis in vascular cognitive impairment. Eur Neurol. 2001;46:63-69.
17. Arntzen KA, Mathiesen EB. Subclinical carotid atherosclerosis and cognitive function. Acta Neurol Scand. 2011;124:18-22.
18. Lekakis JP, Zakopoulos NA, Protogerou AD, Papaioannou TG, Kotsis VT, Pitiriga VC, et al. Arterial stiffness assessed by pulse wave analysis in essential hypertension: relation to 24-h blood pressure profile. Int J Cardiol. 2005;102:391-395.
19. Masugata H, Senda S, Yoshikawa K, Yoshihara Y, Daikuhara H, Ayada Y, et al. Relationships between echocardiographic findings, pulse wave velocity, and carotid atherosclerosis in type 2, diabetic patients. Hypertens Res. 2005;28:965-971.
20. Dufouil C, Godin O, Chalmers J, Coskun O, MacMahon S, Tzourio-Mazoyer N, et al. Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke. 2009;40:2219-2221.
21. Kearney-Schwartz A, Rossignol P, Bracard S, Felblinger J, Fay R, Boivin JM, et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke. 2009;40:1229-1236.
22. Gorelick PB, Scuteri A, Black SE, DeCarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia. Stroke. 2011;42:2672-2713.
23. Mitchell SV. Inflammatory markers and stroke. Curr Cardiol Rep. 2009;11(1):12-20.
24. Nishida H, Horio T, Suzuki Y, Iwashima Y, Tokudome T, Yoshihara F, et al. Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: comparison with C-reactive protein. Cytokine. 2011;53(3):342-346.
25. Ridker PM, Silvertown JD. Inflammation, C-reactive protein, and atherothrombosis. J Periodontol.2008;79(SUPPL.8):1544-1551.
26. Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM, Kastelein JJP, et al. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med. 2008;359:2195-2207.
27. Castillo J, Alvarez-Sabin J, Martinez-Vila E, Montaner J, Sobrino T, Vivancos J. Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study. J Neurol. 2009;256(2):217-224.
28. Purroy F, Montaner J, Molina CA, Delgado P, Arenillas JF, Chacon P, et al. C-reactive protein predicts further ischaemic events in transient ischemic attack patients. Acta Neurol Scand. 2007;115(1):60-66.
29. Datta S, Iqbal Z, Prasad KR. Comparison between serum hsCRP and LDL cholesterol for search of a better predictor for ischemic heart disease. Indian J Clin Biochem. 2011;26(2):210-213.
30. Alexandrov AV, Bladin CF, Norris JW. Intracranial blood flow velocities in acute ischemic stroke. Stroke. 1994;25:1378-1383.
31. Chida Y, Kokubo Y, Sato S, Kuge A, Takemura S, Kondo R, et al. The alterations of oligodendrocyte, myelin in corpus callosum, and cognitive dysfunction following chronic cerebral ischemia in rats. Brain Res. 2011;1414(26):22-31.